Pneumococcal and Hemophilus vaccination: real world effectivity including pulmonary diseases

A. Torres (Barcelona, Spain)

Source: International Congress 2019 – Vaccines against respiratory infections
Session: Vaccines against respiratory infections
Session type: Hot topic
Number: 5110
Disease area: Respiratory infections

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Torres (Barcelona, Spain). Pneumococcal and Hemophilus vaccination: real world effectivity including pulmonary diseases. International Congress 2019 – Vaccines against respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002

Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013




Role of pneumococcal vaccine on the incidence of childhood empyema
Source: Breathe 2010; 6: 366-367
Year: 2010

Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine
Source: Eur Respir J 2013; 42: 1595-1603
Year: 2013



Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016

Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly
Source: Eur Respir J 2010; 36: 608-614
Year: 2010



Should pneumococcal vaccines be used to prevent LRTI?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009

Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany
Source: Virtual Congress 2020 – How do different treatment strategies translate into costs
Year: 2020




Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019




Evolutionary trend of invasive pneumococcal disease according to serotypes
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013

Influenza and pneumoccocal vaccination protect against all cause mortality in COPD
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008

Simultaneous use of probiotics and vaccines for prevention of pneumonia and respiratory infections in servicemen
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006

Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019